RU93042446A - METHOD OF TREATMENT OF ONCOLOGICAL PATIENTS - Google Patents

METHOD OF TREATMENT OF ONCOLOGICAL PATIENTS

Info

Publication number
RU93042446A
RU93042446A RU93042446/14A RU93042446A RU93042446A RU 93042446 A RU93042446 A RU 93042446A RU 93042446/14 A RU93042446/14 A RU 93042446/14A RU 93042446 A RU93042446 A RU 93042446A RU 93042446 A RU93042446 A RU 93042446A
Authority
RU
Russia
Prior art keywords
treatment
urea
preparations
cadmium
drugs
Prior art date
Application number
RU93042446/14A
Other languages
Russian (ru)
Other versions
RU2071767C1 (en
Inventor
Б.Я. Качугина
Л.А. Качугин
Э.Я. Краснокутская
Original Assignee
Б.Я. Качугина
Л.А. Качугин
Э.Я. Краснокутская
Filing date
Publication date
Application filed by Б.Я. Качугина, Л.А. Качугин, Э.Я. Краснокутская filed Critical Б.Я. Качугина
Priority to RU93042446A priority Critical patent/RU2071767C1/en
Priority claimed from RU93042446A external-priority patent/RU2071767C1/en
Publication of RU93042446A publication Critical patent/RU93042446A/en
Application granted granted Critical
Publication of RU2071767C1 publication Critical patent/RU2071767C1/en

Links

Claims (1)

Изобретение относится к области медицины и может быть использовано для лечения онкологических больных. Цель изобретения - повышение эффективности лечения путем использования препаратов, являющихся не токсичными для организма, что позволяет использовать их в достаточных дозах и сроках, обеспечивающих полное излечение больного. Эти препараты обладают высокой эффективностью против опухолей и способствуют повышению иммунных сил больного. Предложены препараты: семикарбазид солянокислый, мочевина, препараты галогенидов кадмия, в частности кадмий йодид, а также окислы стабильного изотопа кадмия с массовым числом 113. Для сокращения сроков лечения практически вдвое используются препараты стабильных изотопов гадолиния, в частности окислы его изотопа с массовым числом 155-157. Этот препарат также не токсичен. В сочетании с мочевиной и питьевой содой может использоваться глюцин, что усиливает проникающую способность мочевины к раковым клеткам, страдающим от ее отсутствия.The invention relates to the field of medicine and can be used for the treatment of cancer patients. The purpose of the invention is to increase the effectiveness of treatment through the use of drugs that are non-toxic to the body, which allows them to be used in sufficient doses and periods that ensure the complete cure of the patient. These drugs are highly effective against tumors and contribute to the improvement of the immune forces of the patient. The following preparations are proposed: semicarbazide hydrochloric acid, urea, cadmium halide preparations, in particular cadmium iodide, as well as oxides of a stable cadmium isotope with a mass number of 113. For shortening the treatment time, preparations of stable gadolinium isotopes, in particular oxides of its isotope with a mass number of 155, are used to shorten the treatment time. 157. This drug is also non-toxic. In combination with urea and baking soda, glucine can be used, which increases the penetrating ability of urea to cancer cells suffering from its absence.
RU93042446A 1993-08-26 1993-08-26 Method of treatment of oncological patients RU2071767C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93042446A RU2071767C1 (en) 1993-08-26 1993-08-26 Method of treatment of oncological patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93042446A RU2071767C1 (en) 1993-08-26 1993-08-26 Method of treatment of oncological patients

Publications (2)

Publication Number Publication Date
RU93042446A true RU93042446A (en) 1996-06-10
RU2071767C1 RU2071767C1 (en) 1997-01-20

Family

ID=20146901

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93042446A RU2071767C1 (en) 1993-08-26 1993-08-26 Method of treatment of oncological patients

Country Status (1)

Country Link
RU (1) RU2071767C1 (en)

Similar Documents

Publication Publication Date Title
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
RU93004764A (en) AMIDA SULFAMIDO-AND SULFAMIDOKARBONYLPYRIDIN-2-CARBIC ACIDS, THEIR Pyridine-N-OXIDES, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS MEDICINE PREPARATIONS
Lange et al. Prolonged intermittent steroid therapy for nephrosis in children and adults
RU95101385A (en) Products containing g-csf and tnf-binding protein
RU93042446A (en) METHOD OF TREATMENT OF ONCOLOGICAL PATIENTS
Jolleys Treatment of shingles and post-herpetic neuralgia.
Coffey et al. Swineherd's disease (aseptic meningitis) due to Leptospira pomona
Pageau et al. Systemic Protection against Radiation: I. Effect of an Elemental Diet on Hematopoietic and Immunologic Systems in the Rat
Taylor et al. The effects of tetracycline on the deposition of plutonium and related elements, in rat bone
WO1992013563A1 (en) Antitumoral preparation and method of making same
Bitawha et al. Herbal treatment of malaria—four case reports from the Rukararwe Partnership Workshop for Rural Development (Uganda)
Awwaad et al. Vacuolization of leukocytes and bone marrow aplasia due to chloramphenicol toxicity
RU2196576C1 (en) Method of treatment of patients with hemorrhagic fever and renal syndrome
Glasky et al. The Role of Cell-Mediated Immunity in the Therapeutic Action of Isoprinosine of Viral Disease Processes
RU2071767C1 (en) Method of treatment of oncological patients
SU1261665A1 (en) Method of treatment of thymomegalia of children
RU2108806C1 (en) Method of immune system correction
RU2141838C1 (en) Body protection medicine against environmental damaging effects and method of treatment ionizing radiation effects
RU2032424C1 (en) Method for treating radial leukopenia
RU97115801A (en) METHOD FOR TREATING STENOSING LARYNGOTRACHAITIS IN CHILDREN
RU2002129102A (en) TREATMENT OF SEPARATE DOSES OF AGENTS WITH VASCULAR DESTRUCTIVE ACTIVITY
RU1812993C (en) Method for parodontitis treatment
张远仲 The Conquest of Smallpox
RU1821218C (en) Antiepileptic drug for treating spasticless forms of epilepsy
Hertert et al. Electroanesthesia for military application.